1. Clinical Decision Support (CDS) Regulatory Boundary
Under Section 520(o)(1)(E) of the United States FD&C Act and the FDA CDRH Final Guidance Clinical Decision Support Software (September 2022), software providing patient-specific health recommendations directly to consumers is regulated as a medical device if it guides clinical diagnosis or treatment.
Tovelu does not provide clinical decision support:
- No patient-specific clinical diagnosis or pathology triage.
- Users are categorized by behavioral lifestyle habits, not disease pathophysiology.
- Zero closed-loop clinical recommendations or prescription titration.
2. Pharmacological Independence
Tovelu holds zero pharmacy, drug dispensing, or prescribing licensing in any jurisdiction worldwide. Tovelu does not recommend, evaluate, or dispense prescription pharmaceuticals, controlled substances, off-label therapies (such as GLP-1 agonists or hormone replacement), or clinical dosages.
3. Healthcare Professional Non-Reliance Clause
If you are a licensed physician, clinical dietitian, or allied health professional accessing Tovelu:
- You agree to exercise independent clinical judgment and not rely on Tovelu scores or summaries as diagnostic evidence.
- Referencing Tovelu does not create malpractice liability for Tovelu or its founder (Ajay Sen).
- Tovelu does not function as an Electronic Health Record (EHR) under HIPAA or EU MDR standards.
4. Academic & Scientific Citation Standards
Tovelu references published human clinical trials and meta-analyses to explain the biological rationale behind healthy habits. These citations are strictly educational context. Individual biological variance (genetics, microbiome, comorbidities) means study findings cannot be extrapolated as guaranteed personal clinical outcomes.